Penn Medicine Provider
Dermatology
Anna Kersh, MD, PhD
4.9
(750)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Emory University
  • Residency: Kettering Medical Center
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

750 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
good support staff
May 2025
5.0
5.0
doctor is remarkable: thorough, patient and knowledgeable
May 2025
5.0
5.0
she's the best!
May 2025
5.0
5.0
very professional

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kersh is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Huang J, Sati S, Murphy C, Spencer CA, Rapp E, Prouty SM, Korte S, Ahart O, Sheng E, Jones P, Kersh AE, Leung D, Leung TH. Granulocyte colony stimulating factor promotes scarless tissue regeneration , Cell Rep, 43(10): 2024,114742

Kersh AE, Sati S, Huang J, Murphy C, Ahart O, Leung TH. CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in lichen planus , JCI Insight, 9(20): 2024,e179899

Sati S, Huang J, Kersh AE, Jones P, Ahart O, Murphy C, Prouty SM, Hedberg ML, Jain V, Gregory SG, Leung DH, Seykora JT, Rosenbach M, Leung TH. Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases , J Clin Invest, 134(17): 2024,e178711

Abbott JJ, Jiang AJ, Rauck C, Frank DM, Fortuna D, Kersh A, Rubin AI. Cutaneous metastatic gastric carcinoma with plasmacytoid features: A novel histopathologic pitfall in the diagnosis of primary cutaneous plasmacytoma , J Cutan Pathol, 50(1): 2023,8-11

Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele K, Forrestel A, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH. Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome , J Clin Invest, 133: 2023,e162137

Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H. Targeted therapy guided by molecular identification of PIK3R1 mutation in acute febrile neutrophilic dermatosis , J Clin Invest, 133(1): 2023,e162137

Torre EA, Kersh AE, Fischer AS, Xu X, Rosenbach M, Shields BE. Angiokeratoma-like purpuric palmar nodules following chemotherapy , Dermatol Online J, 27(8): 2021

Kersh AE, Johansen M, Ojeaga A, de la Feld S. Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis , Dermatitis, 32(2): 2021,86-93

Kersh AE, Schuchter LM, Elenitsas R, Chu EY. Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy , Immunotherapy, 12(13): 2020,951-956

Kersh AE, Feldman RJ. Autoimmune Sequelae Following Rituximab Therapy: A Review of the Literature and Potential Immunologic Mechanisms , J Clin Rheumatol, 24(8): 2018,427-435